Abstract:Abstract Abstract 4069 Myeloid derived suppressor cells (MDSCs) are a group of heterogeneous cells, derived from bone marrow progenitor cells and immature myeloid cells. In tumor development and progression, MDSCs play a role of immunosuppressive effect. Recently, researchers found that granulocyte colony-stimulating factor (G-CSF) could mobilize MDSCs from bone marrow (BM) to peripheral blood (PB), but there is unknown about the effect of G-CSF to MDSCs in the human body and the relationship between MDSCs and graft-verse-host disease (GVHD). So we investigated the association between MDSCs and acute graft-verse-host disease (aGVHD). The expression of MDSCs and adhesion molecules in the BM, PB and peripheral blood stem cell grafts in 30 related donors, were detected by flow cytometry before and after recombined human G-CSF (rhG-CSF) mobilization. The expression of arginase (ARG) and inducible nitric oxide synthase (iNOS) were detected by enzyme-linked immunosorbent assay. According to the median number of MDSCs in peripheral blood stem cell harvests (9.60×106/kg), 30 leukemia patients who underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT) were divided into two groups, high MDSCs group and low MDSCs group. The hematopoietic/immune reconstitution, incidence of aGVHD, relapse, and survival rate were compared between two groups. MDSCs could be detected in the blood and BM in healthy donors, the proportion in nuclear cells in the blood and BM was 0.30% ± 0.09% and 0.53% ± 0.16%, respectively. MDSCs in BM was higher than that in PB (P <0.001). After 5 days of rhG-CSF mobilization, the proportion in the blood and BM was 0.66% ± 0.28% and 0.72% ± 0.13%, respectively. The difference between proportion in the blood before and after mobilization was significant (P =0.017). Adhesion molecules on MDSCs surface after rhG-CSF mobilization were significant lower than that before rhG-CSF mobilization, both in blood and BM (P <0.001). The expression of ARG and iNOS after mobilization were significantly higher than that before mobilization (P<0.001), but not in BM (P =0.695, 0.073). There was a significant negative correlation between the number of transplanted MDSCs cells and the grading of aGVHD (correlation coefficient rs =0.445, P =0.014). The difference between the incidence of aGVHD in high MDSCs group and low MDSCs group (20.00% \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb} \usepackage{amsfonts} \usepackage{amsmath} \pagestyle{empty} \begin{document} \(315\) \end{document} vs 66.67% \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb} \usepackage{amsfonts} \usepackage{amsmath} \pagestyle{empty} \begin{document} \(1015\) \end{document}, P =0.011), there was no significant difference between the hematopoietic/immune reconstitution, relapse rate (26.67% \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb} \usepackage{amsfonts} \usepackage{amsmath} \pagestyle{empty} \begin{document} \(415\) \end{document} vs 20.00% \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb} \usepackage{amsfonts} \usepackage{amsmath} \pagestyle{empty} \begin{document} \(315\) \end{document}, P =0.671) and disease-free survival rate (46.7% ±14.2% vs 38.9%±15.8%, P =0.833) in two groups. In conclusion, in the human body, rhG-CSF could transfer more MDSCs from BM into the blood. RhG-CSF mobilization could increase the number of MDSCs in graft, which may be related to low incidence of aGVHD after allo-HSCT. The mechanism of rhG-CSF mobilized MDSCs to blood may be related to adhesion factor on MDSCs surface. The incidence of aGVHD in patients who accepted high MDSCs cells was lower; there was a significantly negative correlation between MDSCs transplant value and the grading of aGVHD. MDSCs cell infusion did not affect the function of immune reconstitution and the effect of graft versus leukemia. Disclosures: Liu: National Natural Science Foundation of China (No.30971300), Science and Technology Planning Project of Guangdong Province of China (No.2009A030200007): Research Funding.

The Effect of Rhg-CSF on MDSC in Bone Marrow and Peripheral Blood Cells

[Effect of Granulocyte Colony Stimulating Factor on Myeloid-Derived Suppressor Cells in the Bone Marrow and Peripheral Blood: a Preliminary Study].

Association Between Mdscs and Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

A Retrospective Study of Autologous Stem Cell Mobilization by G-CSF in Combination with Chemotherapy in Patients with Multiple Myeloma and Lymphoma.

Investigation on related factors of CD 34+ cells in peripheral blood mobilization effect by G-SCF stimulation

Myeloid-derived Suppressor Cells Mobilized by G-CSF in Allografts Correlate with Low Risk of Acute Graft-Versus Host Disease in Patients Undergoing Unmanipulated Allogeneic Blood and Marrow Transplantation (126.18)

Myeloid-Derived Suppressor Cells (Hla-Dr(-/low)cd16(-)cd33(+)) Expanded by Granulocyte Colony-Stimulating Factor Can Prevent Acute Graft-Versus-Host Disease in Humanized Mouse and Patients Following HSCT

Peripheral Blood Stem Cell Mobilization with Low Dose Rhg-Csf in 56 Unrelated Healthy Donors

Experimental Study on Hematopoietic Reconstruction Effects of Peripheral Blood Stem Cells Mobilized by Anti-Cd49d Monoclonal Antibody Plus Rhg-Csf in Mice

Monocytic and Promyelocytic Myeloid-Derived Suppressor Cells May Contribute to G-CSF-induced Immune Tolerance in Haplo-Identical Allogeneic Hematopoietic Stem Cell Transplantation.

Efffects of Rhg-Csf on Healthy Donors

The transplantation effect of pegylated granulocyte colony-stimulating factor mobilized hematopoietic stem cells may be superior to that of G-CSF mobilized hematopoietic stem cells in haploidentical allogeneic hematopoietic cell transplantation

Effects of Rhg-Csf Mobilization on Th17 Cells in Donors' Peripheral Blood and Bone Marrow Grafts

Influence of Recombinant Human Granulocyte Colony Stimulating Factor (Rhg-Csf) on CD34+ Hematopoietic Stem Cells and Regulatory T Cells in Healthy Donors

Effects of rhG-CSF mobilization on immunological characteristics of peripheral blood grafts and steady-state bone marrow

[Factors Affecting Mobilization of Peripheral Blood Stem/progenitor Cells and Apheresis Efficiency from Healthy Donors by Rhg-Csf].

[Effect of Bone Marrow Graft Collection on Composition of Peripheral Blood Stem Cell Grafts from Healthy Donors after Recombinant Human Granulocyte Colony-Stimulating Factor Application in Vivo for Mobilization].

The Effect of G-CSF Mobilization on the Expression of Immunoregulatory-Associated Molecules and G-CSFR Gene in the Peripheral Blood Γδ+ T Cells

[Effects of Rhg-Csf Mobilization on Immunological Properties of Grafts from Peripheral Blood and Bone Marrow].

Modulation of Adhesion Molecule Expression on T Cells in Bone Marrow after in Vivo Rhg-Csf Application

Experimental study on the mobilization effects and mechanisms of granulocyte colony-stimulating factor and stem cell factor to bone marrow mononuclear cells